Imatinib-Induced Hypogammaglobulinemia in Children and Adolescents with Chronic Myeloid Leukemia
Sidharth Totadri(Post Graduate Institute of Medical Education and Research), Deepak Bansal(Post Graduate Institute of Medical Education and Research), Ritu Aggarwal, Amita Trehan(Institute for Postgraduate Medical Education), Shano Naseem(Post Graduate Institute of Medical Education and Research), Richa Jain(Post Graduate Institute of Medical Education and Research), Pankaj Malhotra(Post Graduate Institute of Medical Education and Research), Neelam Varma(Nagpur Institute of Technology), Madhulika Sharma(University of Kansas Medical Center), Shankar Thipparapu(Post Graduate Institute of Medical Education and Research)
Cited by 9
Related Papers
X-Linked Dyskeratosis Congenita Is Predominantly Caused by Missense Mutations in the DKC1 Gene
|The American Journal of Human Genetics|1999|264
Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis – Case report and systematic review
|Journal of Infection|2008|114
Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients
|Asian Journal of Transfusion Science|2014|106
Imatinib has adverse effect on growth in children with chronic myeloid leukemia
|Pediatric Blood & Cancer|2011|95
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF‐1 axis
|Pediatric Blood & Cancer|2013|85